107 related articles for article (PubMed ID: 8210886)
1. [Drug-induced calculi].
Hammann C; Guelpa G
Schweiz Rundsch Med Prax; 1993 Oct; 82(41):1129-32. PubMed ID: 8210886
[TBL] [Abstract][Full Text] [Related]
2. [Drug-induced urinary lithiasis].
Reveillaud RJ; Daudon M
Presse Med; 1983 Oct; 12(38):2389-92. PubMed ID: 6138768
[TBL] [Abstract][Full Text] [Related]
3. [Vitamin C and stone risk. Review of the literature].
Traxer O; Pearle MS; Gattegno B; Thibault P
Prog Urol; 2003 Dec; 13(6):1290-4. PubMed ID: 15000301
[TBL] [Abstract][Full Text] [Related]
4. [Clinical strategies for prevention of drug-induced urinary calculi].
Kohjimoto Y; Sasaki Y; Hara I
Clin Calcium; 2011 Oct; 21(10):1457-63. PubMed ID: 21960230
[TBL] [Abstract][Full Text] [Related]
5. [Drug-induced urinary calculi in 1999].
Daudon M
Prog Urol; 1999 Dec; 9(6):1023-33. PubMed ID: 10658246
[TBL] [Abstract][Full Text] [Related]
6. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
Conte A; Pizá P; García-Raja A
Arch Esp Urol; 1999; 52(1):94-9. PubMed ID: 10101897
[TBL] [Abstract][Full Text] [Related]
7. [Xanthinuria with xanthine lithiasis in a patient with Lesch-Nyhan syndrome under allopurinol therapy].
Rebentisch G; Stolz S; Muche J
Aktuelle Urol; 2004 Jun; 35(3):215-21. PubMed ID: 15258855
[TBL] [Abstract][Full Text] [Related]
8. Re: Pediatric ceftriaxone nephrolithiasis.
Avci Z; Karadag A; Odemis E; Catal F
J Urol; 2005 Sep; 174(3):1153. PubMed ID: 16094092
[No Abstract] [Full Text] [Related]
9. [Functional evaluation in patients with kidney calculi].
Stojimirović B
Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
[TBL] [Abstract][Full Text] [Related]
10. [Detection and diagnosis of drug induced lithiasis].
Daudon M; Protat MF; Réveillaud RJ
Ann Biol Clin (Paris); 1983; 41(4):239-49. PubMed ID: 6139048
[TBL] [Abstract][Full Text] [Related]
11. [Allopurinol therapy of nephrolithiasis].
Wolfram G
Dtsch Med Wochenschr; 1978 Jan; 103(4):147. PubMed ID: 624257
[No Abstract] [Full Text] [Related]
12. [Triamterene and renal calculi].
Daudon M; Protat MF; Réveillaud RJ
Nephrologie; 1982; 3(3):119-23. PubMed ID: 7144994
[TBL] [Abstract][Full Text] [Related]
13. [Drug-induced renal calculi].
Servais A; Daudon M; Knebelman B
Ann Urol (Paris); 2006 Apr; 40(2):57-68. PubMed ID: 16709005
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced renal calculi: epidemiology, prevention and management.
Daudon M; Jungers P
Drugs; 2004; 64(3):245-75. PubMed ID: 14871169
[TBL] [Abstract][Full Text] [Related]
15. Vitamin C supplementation and kidney stone risk.
Pullar JM; Carr AC; Vissers MC
N Z Med J; 2013 Oct; 126(1384):133-4. PubMed ID: 24162642
[No Abstract] [Full Text] [Related]
16. More evidence regarding vitamin C and kidney stone risk.
Mayo Clin Health Lett; 2013 May; 31(5):4. PubMed ID: 24701646
[No Abstract] [Full Text] [Related]
17. Acute oxalate nephropathy after a massive intravenous dose of vitamin C.
Wong K; Thomson C; Bailey RR; McDiarmid S; Gardner J
Aust N Z J Med; 1994 Aug; 24(4):410-1. PubMed ID: 7980244
[No Abstract] [Full Text] [Related]
18. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
Conte A; Pizá P; García-Raja A; Grases F; Costa-Bauzá A; Prieto RM
Arch Esp Urol; 1999 Apr; 52(3):305-10. PubMed ID: 10371752
[TBL] [Abstract][Full Text] [Related]
19. [Microinfections and kidney lithiasis].
Conte Visús A; Grases Freixedas F; Costa-Bauzá A; Pizá Reus P
Arch Esp Urol; 2001 Nov; 54(9):855-60. PubMed ID: 11789365
[TBL] [Abstract][Full Text] [Related]
20. Large ascorbic acid intake.
Poser E
N Engl J Med; 1972 Aug; 287(8):412-3. PubMed ID: 5043534
[No Abstract] [Full Text] [Related]
[Next] [New Search]
